Clinical Trials Directory

Trials / Completed

CompletedNCT00324402

Plasma Brain Natriuretic Peptide Levels in Pregnancy

Status
Completed
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Oklahoma State University Center for Health Sciences · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

To evaluate the maternal blood concentrations of brain natriuretic peptide (BNP) during the second and third trimesters of a normal pregnancy. We will attempt to define a normal range for pregnancy and any outliers that may serve as markers for abnormal cardiovascular physiology.

Detailed description

The brain natriuretic peptide (BNP) is a useful marker for volume overload, increased filling pressures and stretching of the myocardium. The current literature contains limited and unreliable information regarding normal BNP values in pregnancy. After baseline echocardiogram to detect individuals with asymptomatic structural defects, the participants will submit to 3 blood draws during the second and third trimester and at delivery to determine normal pregnancy values.

Conditions

Timeline

Start date
2006-08-01
Completion
2008-06-01
First posted
2006-05-11
Last updated
2020-10-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00324402. Inclusion in this directory is not an endorsement.